Accès à distance ? S'identifier sur le proxy UCLouvain
A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS.
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Poster |
|---|---|
| Publication date | 2012 |
| Language | Anglais |
| Conference | "113th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)", Washington, USA (du 14/03/2012 au 17/03/2012) |
| Journal information | "Clinical Pharmacology and Therapeutics" - Vol. 91, no.S1, p. S107 (mars 2012) |
| Peer reviewed | yes |
| issn | 0009-9236 |
| e-issn | 1532-6535 |
| Publisher | Nature Publishing Group ((United States) New York) |
| Publication status | Publié |
| Affiliation | UCL - SSS/LDRI - Louvain Drug Research Institute |
| Links |
| Bibliographic reference | Elens, Laure. A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS. .113th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) (Washington, USA, du 14/03/2012 au 17/03/2012). In: Clinical Pharmacology and Therapeutics, Vol. 91, no.S1, p. S107 (mars 2012) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/161907 |